GOP lawmakers push Trump’s FDA to make sure clinical trials are diverse ^54.3%

STAT - By John Wilkerson - 7/6/2026, 8:30 AM

Framing Effect 50% - Negativity Bias 32.8% - Post Hoc (False Cause) 32.8%

WASHINGTON — Clinical trial policy got caught up in the Trump administration’s attack on policies related to diversity, equity, and inclusion. Republicans in Congress would like to change that. Days after Trump took office, the Health and Human Services Department began purging all references to DEI from the websites of its agencies.... more